Detalles de la búsqueda
1.
Natalizumab for Achieving Relapse-Free, T1 Gadolinium-Enhancing-Lesion-Free, and T2 Lesion-Free Status in Japanese Multiple Sclerosis Patients: A Phase 2 Trial Subanalysis.
Neurol Ther
; 6(1): 153-159, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28078634
2.
Efficacy, safety, and pharmacokinetics of natalizumab in Japanese multiple sclerosis patients: A double-blind, randomized controlled trial and open-label pharmacokinetic study.
Mult Scler Relat Disord
; 11: 25-31, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28104251
3.
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial.
Neurol Ther
; 6(1): 39-55, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27921221
Resultados
1 -
3
de 3
1
Próxima >
>>